Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 2Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hodgkin Disease 45Lymphoma 22Hematologic Diseases 17Lymphoma, Large-Cell, Anaplastic 15Lymphoma, Non-Hodgkin 11Recurrence 9Lymphoma, T-Cell 8Lymphoma, T-Cell, Cutaneous 6Lymphoma, T-Cell, Peripheral 5Mycosis Fungoides 3Lymphoma, Primary Cutaneous Anaplastic Large Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell 3Leukemia, Myeloid, Acute 3Sezary Syndrome 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Myelodysplastic Syndromes 2Lymphomatoid Papulosis 2Enteropathy-Associated T-Cell Lymphoma 2Dendritic Cell Sarcoma, Interdigitating 2Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Kaposi 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Melanoma 1

Interventions

blinatumomab 5dacetuzumab 4Rituximab 3venetoclax 1tetulomab tetraxetan lu-177 1ponatinib 1pembrolizumab 1ibrutinib 1ficlatuzumab 1durvalumab 1denileukin diftitox 1Tinzaparin 1Standard of Care 1Lutetium 1Lenalidomide 1Gemcitabine 1Everolimus 1Erlotinib Hydrochloride 1Cyclophosphamide 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphatic Diseases × Brentuximab Vedotin × Clear all
NCT01990534 2021-04-09

A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

Takeda

Phase 4 Completed
60 enrolled 21 charts
Lymphoid

Hematologic Diseases, Hodgkin Disease, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡